Zobrazeno 1 - 10 of 160 pro vyhledávání: '"Calzas J"'
1
Akademický článek
Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.
Autor: Carcereny E; Institut Català D'oncologia Badalona- Hospital Germans Trias I Pujol, B-Argo Group, Badalona, Spain. ecarcereny@iconcologia.net., Rodriguez-Abreu D; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Lopez R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Franco F; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Guirado M; Hospital General Universitario de Elche, Elche, Spain., Massutí B; Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain., Cobo M; Hospital Regional Universitario de Málaga, Málaga, Spain., Blasco A; Hospital General Universitario de Valencia, Valencia, Spain., Suay G; Hospital Universitari I Politècnic La Fe, Valencia, Spain., Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain., Ortega AL; Hospital Universitario de Jaén, Jaen, Spain., Sala MA; OSI Bilbao Basurto, Bilbao, Spain., Cordeiro P; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Bernabé R; Hospital Universitario Virgen del Rocío, Seville, Spain., González Larriba JL; Hospital Universitario Clínico San Carlos, Madrid, Spain., Bosch-Barrera J; Josep Trueta and Precision Oncology Group (OncoGIR-Pro), Institut d'Investigacions Biomèdiques de Girona (IDIBGI), Catalan Institute of Oncology, Hospital Universitari Dr, Girona, Spain., Calzas J; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain., Casal J; Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Padilla A; Hospital Universitario, Nuestra Señora De La Candelaria, Santa Cruz de Tenerife, Spain., Sánchez-Hernandez A; Hospital Provincial de Castellón, Castellón, Spain., Provencio M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Dec; Vol. 26 (12), pp. 3218-3225. Date of Electronic Publication: 2024 Jun 11.
Zobrazit plný text záznamu
3
Akademický článek
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.
Autor: Muñoz A; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain., Ay C; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Grilz E; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., López S; Genomics of Complex Diseases Unit, Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain., Font C; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Hospital Clínic, Barcelona, Spain., Pachón V; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Hospital Universitario Ramón y Cajal Madrid, Madrid, Spain., Castellón V; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Complejo Hospitalario de Torrecárdenas, Almería, Spain., Martínez-Marín V; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Hospital Universitario La Paz, Madrid, Spain., Salgado M; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Martínez E; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Calzas J; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Hospital Universitario de Fuenlabrada, Madrid, Spain., Ortega L; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain., Rupérez A; Cancer and Thrombosis Working Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.; Medical Oncology, Fundación Jiménez Díaz, Madrid, Spain., Salas E; Scientific Department, Gendiag.exe, Barcelona, Spain., Pabinger I; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Soria JM; Genomics of Complex Diseases Unit, Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 01; Vol. 41 (16), pp. 2911-2925. Date of Electronic Publication: 2023 Feb 02.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
Autor: Yubero A; Medical Oncology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. ayuberoe@salud.aragon.es., Barquín A; Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid, Spain., Estévez P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Pajares B; Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Sánchez L; Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain., Reche P; Medical Oncology, Hospital Universitario Torrecárdenas, Almería, Spain., Alarcón J; Medical Oncology, Hospital Universitario Son Espases, Mallorca, Spain., Calzas J; Medical Oncology, Hospital Universitario de Fuenlabrada, Madrid, Spain., Gaba L; Department of Medical Oncology, Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic de Barcelona, Institut D'Investigacions Biomèdiques August Pi I Sunyer (Idibaps), Barcelona, Spain., Fuentes J; Medical Oncology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Santaballa A; Medical Oncology, Hospital Universitario i Politècnic la Fe, Valencia, Spain., Salvador C; Medical Oncology, Hospital Lluís Alcanyís de Xàtiva, Xátiva, Spain., Manso L; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Herrero A; Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Taus Á; Medical Oncology, Hospital del Mar, Barcelona, Spain., Márquez R; Medical Oncology, MD Anderson Cancer Center, Madrid, Spain., Madani J; Medical Oncology, Hospital Universitario San Jorge, Huesca, Spain., Merino M; Medical Oncology, Hospital Universitario Infanta Sofía, Madrid, Spain., Marquina G; Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Casado V; Medical Oncology, Fundación Jiménez Díaz, Madrid, Spain., Constenla M; Medical Oncology, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Gutiérrez M; Medical Oncology, Hospital Universitario Txagorritxu, Araba, Spain., Dosil A; Clovis Oncology , Madrid, Spain., González-Martín A; Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain.; Centre for Applied Medical Research, Pamplona, Spain.
Publikováno v: BMC cancer [BMC Cancer] 2022 Nov 08; Vol. 22 (1), pp. 1150. Date of Electronic Publication: 2022 Nov 08.
Zobrazit plný text záznamu
7
Akademický článek
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.
Autor: Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, C/ Manuel de Falla 1, Majadahonda, 28222, Madrid, Spain. mprovenciop@gmail.com., Cobo M; Hospital Regional Universitario de Málaga, Málaga, Spain., Rodriguez-Abreu D; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, C/ Manuel de Falla 1, Majadahonda, 28222, Madrid, Spain., Carcereny E; Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain., Cantero A; Hospital Regional Universitario de Málaga, Málaga, Spain., Bernabé R; Hospital Universitario Virgen del Rocio, Sevilla, Spain., Benitez G; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Castro RL; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Massutí B; Hospital General Universitario de Alicante, Alicante, Spain., Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain., García Campelo R; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Guirado M; Hospital General Universitario de Elche, Elche, Spain., Camps C; Hospital General Universitario de Valencia, Valencia, Spain.; Universidad de Valencia, Valencia, Spain.; CIBERONC, Madrid, Spain., Ortega AL; Hospital Universitario de Jaén, Jaén, Spain., González Larriba JL; Hospital Universitario Clínico San Carlos, Madrid, Spain., Sánchez A; Hospital Provincial de Castellón, Castellón, Spain., Casal J; Complexo Hospitalario de Vigo, Vigo, Spain., Sala MA; OSI Bilbao Basurto, Bibao, Spain., Juan-Vidal O; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bosch-Barrera J; Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta, Girona, Spain., Oramas J; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Dómine M; Hospital Universitario Fundación Jiménez Díaz. IIS-FJD, Madrid, Spain., Trigo JM; Hospital Universitario Virgen de la Victoria, Málaga, Spain., Blanco R; Consorci Sanitari de Terrassa, Barcelona, Spain., Calzas J; Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain., Morilla I; Complejo Hospitalario de Navarra, Navarra, Spain., Padilla A; Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain., Pimentao J; Department of Electrical Engineering, NOVA School of Science and Technology, Universidade Nova de Lisboa, Lisbon, Portugal., Sousa PA; Department of Electrical Engineering, NOVA School of Science and Technology, Universidade Nova de Lisboa, Lisbon, Portugal., Torrente M; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, C/ Manuel de Falla 1, Majadahonda, 28222, Madrid, Spain.
Publikováno v: BMC cancer [BMC Cancer] 2022 Jul 05; Vol. 22 (1), pp. 732. Date of Electronic Publication: 2022 Jul 05.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje